- May 16, 2016
- 946
- 93
Dr Oz? LOL
The truth about using chloroquine to fight coronavirus pandemic
The Clinical Trial in France consisted of ONLY 26 patients
Of the 26...
Only 20 completed the trial.
1 left the hospital before trail ended.
1 could not tolerate the medication
3 went to the ICU
1 Died
If this is 100% cured, then I've been doing math wrong my entire life.... All of the "Control" patients who did not receive the drug appear to have survived... Hmmmmmm?
From the actual Clinical Trial document:
A total of 26 patients received
hydroxychloroquine and 16 were control patients. Six hydroxychloroquine-treated patients
were lost in follow-up during the survey because of early cessation of treatment. Reasons are
as follows: three patients were transferred to intensive care unit, including one transferred on
day2 post-inclusion who was PCR-positive on day1, one transferred on day3 post-inclusion
who was PCR-positive on days1-2 and one transferred on day4 post-inclusion who was PCR-
positive on day1 and day3; one patient died on day3 post inclusion and was PCR-negative on
day2; one patient decided to leave the hospital on day3 post-inclusion and was PCR-negative
on days1-2; finally, one patient stopped the treatment on day3 post-inclusion because of
nausea and was PCR-positive on days1-2-3. The results presented here are therefore those of
36 patients (20 hydroxychloroquine-treated patients and 16 control patients). None of the
control patients was lost in follow-up.
The truth about using chloroquine to fight coronavirus pandemic
The Clinical Trial in France consisted of ONLY 26 patients
Of the 26...
Only 20 completed the trial.
1 left the hospital before trail ended.
1 could not tolerate the medication
3 went to the ICU
1 Died
If this is 100% cured, then I've been doing math wrong my entire life.... All of the "Control" patients who did not receive the drug appear to have survived... Hmmmmmm?
From the actual Clinical Trial document:
A total of 26 patients received
hydroxychloroquine and 16 were control patients. Six hydroxychloroquine-treated patients
were lost in follow-up during the survey because of early cessation of treatment. Reasons are
as follows: three patients were transferred to intensive care unit, including one transferred on
day2 post-inclusion who was PCR-positive on day1, one transferred on day3 post-inclusion
who was PCR-positive on days1-2 and one transferred on day4 post-inclusion who was PCR-
positive on day1 and day3; one patient died on day3 post inclusion and was PCR-negative on
day2; one patient decided to leave the hospital on day3 post-inclusion and was PCR-negative
on days1-2; finally, one patient stopped the treatment on day3 post-inclusion because of
nausea and was PCR-positive on days1-2-3. The results presented here are therefore those of
36 patients (20 hydroxychloroquine-treated patients and 16 control patients). None of the
control patients was lost in follow-up.
Last edited: